At some point within the next few weeks, Brewers outfielder Ryan Braun will have the opportunity to plead his innocence against a charge that he was taking performance-enhancing drugs around the start of the 2011 postseason. But he faces great odds.
The evidence against him comes in the form of a test, administered in either late September or early October, that had a positive reading for elevated levels of testosterone. That test was then passed along to the World Anti-Doping Agency lab in Montreal, where it was determined through further examination that the testosterone was synthetic — not produced by Braun’s body.
Braun might argue that the result was a false-positive, but an expert in the field of drug testing told Jeff Passan of Yahoo! Sports last month that those are “almost impossible” with today’s technology. Braun might say that result was triggered by a prescribed medication — something non-performance-enhancing — but how can he prove that and would it really matter if he could? The test showed insanely high levels of unnatural testosterone. However that testosterone arrived in Braun’s system, it’s against the rules for it to be there.
And even if Braun is telling the truth, and has never put synthetic testosterone into his body, a test that boasts an accuracy rating of nearly 100 percent says that the stuff was, at one point, present.
Which leads us to a report from Tom Haudricourt of the Milwaukee Journal Sentinel, who was told this weekend by an “MLB official familiar with the process” that Braun’s 50-game suspension is unlikely to be overturned. The 2011 NL MVP deserves his day in court, and he’ll get it later this month when he presents his case in front of an arbitrator, but it’s nearly certain that he’ll miss close to one-third of the 2012 campaign.
It was assumed already, but Mike Scioscia made it official during Monday’s press conference for new general manager Billy Eppler that he will return as Angels manager in 2016.
Scioscia, the longest-tenured manager in the majors, has been at the helm with the Angels since 2000. There was a clause in his contract which allowed him to opt out after the 2015 season, but he has decided to stay put. He still has three years and $15 million on his contract, which runs through 2018.
Jerry Dipoto resigned as Angels general manager in July amid tension with Scioscia, so there were naturally questions today about what to expect with first-time GM Eppler in the fold. According to David Adler of MLB.com, Scioscia isn’t concerned.
“I think we’re going to mesh very well,” Scioscia said. “If we adjust, or maybe he adjusts to some of the things, there’s going to be collaboration that’s going to make us better.”
Eppler is the fourth general manager during Scioscia’s tenure with the team.
After winning the AL West last season, the Angels finished 85-77 this season and narrowly missed the playoffs. The team hasn’t won a postseason game since 2009.
Astros center fielder Carlos Gomez sat out the final series of the regular season in order to rest a strained left intercostal muscle, but there was good news coming out of a workout today in advance of Tuesday’s Wild Card game vs. the Yankees.
This has been a lingering issue for Gomez, who missed 13 straight games with the injury last month. He aggravated the strain on a throw to home plate last Wednesday and was forced to sit while the Astros fought to keep their season alive. Astros manager A.J. Hinch told reporters last week that Gomez’s injury would typically take 45-50 days to recover from, so it’s fair to wonder how productive he can be during the postseason.
Gomez mostly struggled after coming over from the Brewers at the trade deadline, batting .242 with four home runs and a .670 OPS over 41 games.